Clinical trial
An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and…
NCT00192023 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00192023 |
|---|---|
| Title | An Italian Study of the Efficacy of Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) and Comorbid Oppositional Defiant Disorder (ODD). |
| Official title | An Italian Randomised, Double-blind Placebo Controlled Study of the Efficacy of Atomoxetine Hydrochloride in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder, Oppositional Defiant Disorder |
| Intervention type | Drug |
| Interventions | atomoxetine 0.5 mg/kg/day, placebo, atomoxetine 1.2 mg/kg/day, atomoxetine 1.2-1.4 mg/kg/day |
| Enrollment | 139 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | Jan 18, 2010 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: